All In Biotech

Free tool

FAERS Monitor: Indomethacin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018829 or its brand name (Indomethacin, Indomethacin). Reports on generic versions are filed under their own applications.

Reports

11,101

Serious

9,017

81% of reports

Hospitalization

3,780

Death reported

1,293

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,316
  • fatigue1,063
  • headache978
  • off label use968
  • arthralgia957
  • pain851
  • nausea840
  • diarrhoea837
  • dizziness805
  • vomiting689
  • dyspnoea681
  • asthenia599
  • pruritus593
  • malaise585
  • pyrexia574

Reports by year received

View as table
YearReports
2004218
2005264
2006278
2007257
2008266
2009307
2010270
2011371
2012458
2013314
2014280
2015385
2016540
2017466
2018649
2019707
2020583
2021716
2022981
2023843
2024873
2025732
2026342

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,058 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
arthralgiaSignal9574.44.12,527
pyrexiaSignal5743.12.9851
dizzinessSignal8053.12.91,140
astheniaSignal5993.02.8822
headacheSignal9783.02.81,303
pruritusSignal5932.92.7763
vomitingSignal6892.82.6800
painSignal8512.62.5880
fatigueSignal1,0632.62.41,074
malaiseSignal5852.52.3550
diarrhoeaSignal8372.52.3745
dyspnoeaSignal6812.32.1501
off label useSignal9682.12.0577
nauseaSignal8402.01.9443
drug ineffective1,3161.91.8590

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.